RxDoctor Payments Data

Anna Kulidjian, MD

Orthopaedic Surgery · la Jolla, CANPI 1215183066

Payments from drug & device makers

$340,261in general payments, 2019–2025

Across 290 payments — averaging $1173.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$170K
  • Depuy Synthes Products, Inc.$112K
  • Novartis$55K
  • Johnson & Johnson$2K
  • Daiichi Sankyo Inc.$980
  • Smith+Nephew$235
  • plus $563 from 10 others

What the payments were for

  • Consulting fees$165,83582%
  • Travel & lodging$33,28916%
  • Food & beverage$4,1402%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medical Device Business Services, Inc.121$169,923
Depuy Synthes Products, Inc.123$111,695
Novartis1$54,964
Johnson & Johnson(2 entities)17$1,901
Daiichi Sankyo Inc.9$980
Smith+Nephew6$235
Stryker3$208
Zimmer Biomet2$205
Elevate Surgical Co1$33
Carbofix Orthopedics Inc1$22
Pixee Medical Inc.1$19
Orthofix Medical, Inc.1$17
Sanara Medtech Inc.1$17
Biocomposites Inc1$16
KCI USA, Inc.1$14
Misonix Inc1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$340,261 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$450,392
Medicare patients
670
Services billed
3,818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin101$191
Mupirocin27$187
Methylprednisolone23$144
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$22

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in la Jolla

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →